Hypermutable bacteria isolated from humans - A critical analysis

Microbiology

Volumn 152, Issue 9, 2006, Pages 2505-2514

  Hall, Lucinda M C ^a   Henderson Begg, Stephanie K ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA GLYCOSYLASE MUTY; PROTEIN MUTS;

BACTERIUM ISOLATION; BACTERIUM MUTANT; CYSTIC FIBROSIS; ESCHERICHIA COLI; GENE INACTIVATION; GENE MUTATION; HAEMOPHILUS INFLUENZAE; HELICOBACTER PYLORI; MICROBIOLOGICAL EXAMINATION; MUTATION RATE; NEISSERIA MENINGITIDIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; SALMONELLA; SCIENTIFIC LITERATURE; SHIGELLA; SPECIES DIFFERENCE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

BACTERIA; BASE PAIR MISMATCH; CYSTIC FIBROSIS; GENES, BACTERIAL; HELICOBACTER PYLORI; HUMANS; MUTATION; NEISSERIA MENINGITIDIS; PSEUDOMONAS AERUGINOSA; SEROTYPING;

HELICOBACTER PYLORI; NEISSERIA MENINGITIDIS; PSEUDOMONAS AERUGINOSA;

EID: 33748700552     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.29079-0     Document Type: Review

References (54)

1. Baquero, M. R., Nilsson, A. I., Turrientes Mdel, C., Sandvang, D., Galan, J. C., Martinez, J. L., Frimodt-Moller, N., Baquero, F. & Andersson, D. I. (2004). Polymorphic mutation frequencies in Escherichia coli: emergence of weak mutators in clinical isolates. J Bacteriol 186, 5538-5542.
2. Baquero, M. R., Galan, J. C., del Carmen Turrientes, M., Canton, R., Coque, T. M., Martinez, J. L. & Baquero, F. (2005). Increased mutation frequencies in Escherichia coli isolates harboring extended-spectrum beta-lactamases. Antimicrob Agents Chemother 49, 4754-4756.
3. Bjedov, I., Tenaillon, O., Gerard, B., Souza, V., Denamur, E., Radman, M., Taddei, F. & Matic, I. (2003). Stress-induced mutagenesis in bacteria. Science 300, 1404-1409.
4. Bjorkholm, B., Sjolund, M., Falk, P. G., Berg, O. G., Engstrand, L. & Andersson, D. I. (2001). Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori. Proc Natl Acad Sci U S A 98, 14607-14612.
5. Blazquez, J. (2003). Hypermutation as a factor contributing to the acquisition of antimicrobial resistance. Clin Infect Dis 37, 1201-1209.
6. Blazquez, J., Oliver, A. & Gomez-Gomez, J. M. (2002). Mutation and evolution of antibiotic resistance: antibiotics as promoters of antibiotic resistance? Curr Drug Targets 3, 345-349.
7. Bridges, B. A. (2001). Hypermutation in bacteria and other cellular systems. Philos Trans R Soc Lond B Biol Sci 356, 29-39.
8. Bucci, C., Lavitola, A., Salvatore, P., Del Giudice, L., Massardo, D. R., Bruni, C. B. & Alifano, P. (1999). Hypermutation in pathogenic bacteria: frequent phase variation in meningococci is a phenotypic trait of a specialized mutator biotype. Mol Cell 3, 435-445.
9. Chopra, I., O'Neill, A. J. & Miller, K. (2003). The role of mutators in the emergence of antibiotic-resistant bacteria. Drug Resist Updat 6, 137-145.
10. Ciofu, O., Riis, B., Pressler, T., Poulsen, H. E. & Hoiby, N. (2005). Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation. Antimicrob Agents Chemother 49, 2276-2282.
11. Crane, G. J., Thomas, S. M. & Jones, M. E. (1996). A modified Luria-Delbruck fluctuation assay for estimating and comparing mutation rates. Mutat Res 354, 171-182.
12. Davidsen, T., Bjoras, M., Seeberg, E. C. & Tonjum, T. (2005). Antimutator role of DNA glycosylase MutY in pathogenic Neisseria species. J Bacteriol 187, 2801-2809.
13. del Campo, R., Morosini, M. I., de la Pedrosa, E. G., Fenoll, A., Munoz-Almagro, C., Maiz, L., Baquero, F. & Canton, R. (2005). Population structure, antimicrobial resistance, and mutation frequencies of Streptococcus pneumoniae isolates from cystic fibrosis patients. J Clin Microbiol 43, 2207-2214.
14. Denamur, E., Bonacorsi, S., Giraud, A. & 8 other authors (2002). High frequency of mutator strains among human uropathogenic Escherichia coli isolates. J Bacteriol 184, 605-609.
15. Drake, J. W. (1991). A constant rate of spontaneous mutation in DNA-based microbes. Proc Natl Acad Sci U S A 88, 7160-7164.
16. Foster, P. L. (2005). Stress responses and genetic variation in bacteria. Mutat Res 569, 3-11.
17. Garibyan, L., Huang, T., Kim, M. & 8 other authors (2003). Use of the rpoB gene to determine the specificity of base substitution mutations on the Escherichia coli chromosome. DNA Repair 2, 593-608.
18. Gillespie, S. H., Basu, S., Dickens, A. L., O'Sullivan, D. M. & McHugh, T. D. (2005). Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates. J Antimicrob Chemother 56, 344-348.
19. Giraud, A., Matic, I., Tenaillon, O., Clara, A., Radman, M., Fons, M. & Taddei, F. (2001). Costs and benefits of high mutation rates: adaptive evolution of bacteria in the mouse gut. Science 291, 2606-2608.
20. Gutierrez, O., Juan, C., Perez, J. L. & Oliver, A. (2004). Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients. Antimicrob Agents Chemother 48, 3573-3575.
21. Henderson-Begg, S. K., Livermore, D. M. & Hall, L. M. (2006). Effect of subinhibitory concentrations of antibiotics on mutation frequency in Streptococcus pneumoniae. J Antimicrob Chemother 57, 849-854.
22. Kim, M., Huang, T. & Miller, J. H. (2003). Competition between MutY and mismatch repair at A × C mispairs in vivo. J Bacteriol 185, 4626-4629.
23. LeClerc, J. E., Li, B., Payne, W. L. & Cebula, T. A. (1996). High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 274, 1208-1211.
24. Li, B., Tsui, H. C., LeClerc, J. E., Dey, M., Winkler, M. E. & Cebula, T. A. (2003). Molecular analysis of mutS expression and mutation in natural isolates of pathogenic Escherichia coli. Microbiology 149, 1323-1331.
25. Luria, S. E. & Delbrück, M. (1943). Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28, 491-511.
26. Macia, M. D., Blanquer, D., Togores, B., Sauleda, J., Perez, J. L. & Oliver, A. (2005). Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections. Antimicrob Agents Chemother 49, 3382-3386.
27. Mao, E. F., Lane, L., Lee, J. & Miller, J. H. (1997). Proliferation of mutators in a cell population. J Bacteriol 179, 417-422.
28. Martin, P., Sun, L., Hood, D. W. & Moxon, E. R. (2004). Involvement of genes of genome maintenance in the regulation of phase variation frequencies in Neisseria meningitidis. Microbiology 150, 3001-3012.
29. Miller, K., O'Neill, A. J. & Chopra, I. (2002). Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes. J Antimicrob Chemother 49, 925-934.
30. Morosini, M. I., Baquero, M. R., Sanchez-Romero, J. M., Negri, M. C., Galan, J. C., del Campo, R., Perez-Diaz, J. C. & Baquero, F. (2003). Frequency of mutation to rifampin resistance in Streptococcus pneumoniae clinical strains: hexA and hexB polymorphisms do not account for hypermutation. Antimicrob Agents Chemother 47, 1464-1467.
31. Notley-McRobb, L., Pinto, R., Seeto, S. & Ferenci, T. (2002a). Regulation of mutY and nature of mutator mutations in Escherichia coli populations under nutrient limitation. J Bacteriol 184, 739-745.
32. Notley-McRobb, L., Seeto, S. & Ferenci, T. (2002b). Enrichment and elimination of mutY mutators in Escherichia coli populations. Genetics 162, 1055-1062.
33. Oliver, A., Canton, R., Campo, P., Baquero, F. & Blazquez, J. (2000). High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288, 1251-1254.
34. Oliver, A., Baquero, F. & Blazquez, J. (2002a). The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants. Mol Microbiol 43, 1641-1650.
35. Oliver, A., Sanchez, J. M. & Blazquez, J. (2002b). Characterization of the GO system of Pseudomonas aeruginosa. FEMS Microbiol Lett 217, 31-35.
36. O'Neill, A. J. & Chopra, I. (2002). Insertional inactivation of mutS in Staphylococcus aureus reveals potential for elevated mutation frequencies, although the prevalence of mutators in clinical isolates is low. J Antimicrob Chemother 50, 161-169.
37. Pang, P. P., Lundberg, A. S. & Walker, G. C. (1985). Identification and characterization of the mutL and mutS gene products of Salmonella typhimurium LT2. J Bacteriol 163, 1007-1015.
38. Perez-Capilla, T., Baquero, M. R., Gomez-Gomez, J. M., Ionel, A., Martin, S. & Blazquez, J. (2005). SOS-independent induction of dinB transcription by beta-lactam-mediated inhibition of cell wall synthesis in Escherichia coli. J Bacteriol 187, 1515-1518.
39. Prunier, A. L. & Leclercq, R. (2005). Role of mutS and mutL genes in hypermutability and recombination in Staphylococcus aureus. J Bacteriol 187, 3455-3464.
40. Prunier, A. L., Malbruny, B., Laurans, M., Brouard, J., Duhamel, J. F. & Leclercq, R. (2003). High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains. J Infect Dis 187, 1709-1716.
41. Richardson, A. R. & Stojiljkovic, I. (2001). Mismatch repair and the regulation of phase variation in Neisseria meningitidis. Mol Microbiol 40, 645-655.
42. Richardson, A. R., Yu, Z., Popovic, T. & Stojiljkovic, I. (2002). Mutator clones of Neisseria meningitidis in epidemic serogroup A disease. Proc Natl Acad Sci U S A 99, 6103-6107.
43. Rosche, W. A. & Foster, P. L. (2000). Determining mutation rates in bacterial populations. Methods 20, 4-17.
44. Rosenberg, S. M., Thulin, C. & Harris, R. S. (1998). Transient and heritable mutators in adaptive evolution in the lab and in nature. Genetics 148, 1559-1566.
45. Samrakandi, M. M. & Pasta, F. (2000). Hyperrecombination in Streptococcus pneumoniae depends on an atypical mutY homologue. J Bacteriol 182, 3353-3360.
46. Shaver, A. C., Dombrowski, P. G., Sweeney, J. Y., Treis, T., Zappala, R. M. & Sniegowski, P. D. (2002). Fitness evolution and the rise of mutator alleles in experimental Escherichia coli populations. Genetics 162, 557-566.
47. Sniegowski, P. D., Gerrish, P. J. & Lenski, R. E. (1997). Evolution of high mutation rates in experimental populations of E. coli. Nature 387, 703-705.
48. Sniegowski, P. D., Gerrish, P. J., Johnson, T. & Shaver, A. (2000). The evolution of mutation rates: separating causes from consequences. Bioessays 22, 1057-1066.
49. Tatusov, R. L., Fedorova, N. D., Jackson, J. D. & 14 other authors (2003). The COG database: an updated version includes eukaryotes. BMC Bioinformatics 4, 41.
50. Thomas, S. R., Ray, A., Hodson, M. E. & Pitt, T. L. (2000). Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease. Thorax 55, 795-797.
51. Trong, H. N., Prunier, A. L. & Leclercq, R. (2005). Hypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus. Antimicrob Agents Chemother 49, 2098-2101.
52. Watson, M. E., Jr, Burns, J. L. & Smith, A. L. (2004). Hypermutable Haemophilus influenzae with mutations in mutS are found in cystic fibrosis sputum. Microbiology 150, 2947-2958.
53. Young, D. M. & Ornston, L. N. (2001). Functions of the mismatch repair gene mutS from Acinetobacter sp. strain ADP1. J Bacteriol 183, 6822-6831.
54. Zhao, J. & Winkler, M. E. (2000). Reduction of GC→TA transversion mutation by overexpression of MutS in Escherichia coli K-12. J Bacteriol 182, 5025-5028.